- Home
- CHW vs ORGO Comparison
CHW vs ORGO Comparison
Compare CHW & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHW
- ORGO
- Stock Information
- Founded
- CHW 2007
- ORGO 1985
- Country
- CHW United States
- ORGO United States
- Employees
- CHW N/A
- ORGO N/A
- Industry
- CHW Investment Managers
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CHW Finance
- ORGO Health Care
- Exchange
- CHW Nasdaq
- ORGO Nasdaq
- Market Cap
- CHW 439.4M
- ORGO 480.3M
- IPO Year
- CHW N/A
- ORGO N/A
- Fundamental
- Price
- CHW $6.90
- ORGO $3.47
- Analyst Decision
- CHW
- ORGO Strong Buy
- Analyst Count
- CHW 0
- ORGO 2
- Target Price
- CHW N/A
- ORGO $5.00
- AVG Volume (30 Days)
- CHW 195.2K
- ORGO 523.4K
- Earning Date
- CHW 01-01-0001
- ORGO 02-27-2025
- Dividend Yield
- CHW 9.27%
- ORGO N/A
- EPS Growth
- CHW N/A
- ORGO N/A
- EPS
- CHW N/A
- ORGO N/A
- Revenue
- CHW N/A
- ORGO $455,038,000.00
- Revenue This Year
- CHW N/A
- ORGO $9.65
- Revenue Next Year
- CHW N/A
- ORGO $1.57
- P/E Ratio
- CHW N/A
- ORGO N/A
- Revenue Growth
- CHW N/A
- ORGO 1.34
- 52 Week Low
- CHW $5.07
- ORGO $2.17
- 52 Week High
- CHW $6.54
- ORGO $4.57
- Technical
- Relative Strength Index (RSI)
- CHW 51.23
- ORGO 48.92
- Support Level
- CHW $6.77
- ORGO $3.42
- Resistance Level
- CHW $6.97
- ORGO $3.85
- Average True Range (ATR)
- CHW 0.08
- ORGO 0.19
- MACD
- CHW 0.01
- ORGO 0.03
- Stochastic Oscillator
- CHW 63.88
- ORGO 54.87
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.